Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Efficacy of the oral pentavalent rotavirus vaccine in Mali
Samba O. Sow
*
, Milagritos Tapia
, Fadima C. Haidara
, Max Ciarlet
, Fatoumata Diallo
, Mamoudou Kodio
, Moussa Doumbia
, Rokiatou D. Dembélé
, Oumou Traoré
, Uma U. Onwuchekwa
, Kristen D.C. Lewis
, John C. Victor
,
A. Duncan Steele
, Kathleen M. Neuzil
, Karen L. Kotloff
, Myron M. Levine
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
52
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy of the oral pentavalent rotavirus vaccine in Mali'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Confidence Interval
100%
Pentavalent Rotavirus Vaccine
100%
Mali
100%
Rotavirus Gastroenteritis
80%
Vaccine Effectiveness
60%
Third Dose
60%
Placebo
40%
First Year
40%
Seroresponse
40%
Local Health
40%
Geometric Mean Titer
40%
Point Estimate
40%
Vaccination
20%
Sub-Saharan Africa
20%
Young children
20%
Gastroenteritis
20%
Health Centers
20%
Point-of-care
20%
Traditional Healers
20%
Bangladesh
20%
RotaTeq
20%
Asia
20%
Randomized Placebo-controlled Trial
20%
Ghana
20%
Kenya
20%
Anti-rotavirus
20%
One Dose
20%
Home Visits
20%
Care-seeking
20%
Immunoglobulin
20%
Clinical Scoring System
20%
Vietnam
20%
Per-protocol
20%
Pre-vaccination
20%
Surveillance System
20%
Cultural Practices
20%
Multi-state Trials
20%
Efficacy Analysis
20%
Second Year of Life
20%
Local Custom
20%
Immunogenicity Assessment
20%
Intention-to-treat
20%
Clinical Adverse Events
20%
Other-efficacy
20%
Medicine and Dentistry
Gastroenteritis
100%
Rotavirus Vaccine
100%
Rotavirus
100%
Placebo
60%
Vaccine
60%
Adverse Event
20%
Health Care
20%
Toddlers
20%
Intention-to-Treat Analysis
20%
Immunogenicity
20%
Surveillance System
20%
Scoring System
20%
Immunoglobulin A Antibody
20%
Immunology and Microbiology
Rotavirus Vaccine
100%
Rotavirus
100%
Gastroenteritis
100%
Vaccine Efficacy
60%
Vaccine
60%
Titer
40%
Immunogenicity
20%
Immunoglobulin A Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Gastroenteritis
100%
Rotavirus
100%
Rotavirus Vaccine
100%
Placebo
60%
Vaccine
60%
Adverse Event
20%
Immunogenicity
20%
Immunoglobulin A Antibody
20%
Biochemistry, Genetics and Molecular Biology
Rotavirus
100%
Titer
22%
Immunogenicity
11%
Immunoglobulin A
11%